News

Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder
Key Points Hims & Hers Health is entering the Canadian market.The company will offer a generic version of semaglutide in the ...
Hims & Hers hit with growing number of investor lawsuits after Novo deal exit
Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...
Zacks.com on MSN6h
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.
Zacks.com on MSN3d
Hims & Hers Health and DXC Technology have been highlighted as Zacks Bull and Bear of the Day
HIMS rebounds on GLP-1 growth and rising earnings estimates, while DXC slumps amid falling sales and eroding investor ...
Hims & Hers Health, Inc. (HIMS) Alleged“Deceptive” Marketing Of Wegovy® Triggers Securities Class Actions HIMS Investors With Losses Encouraged To Contact Hagens Berman
National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...
Why Hims & Hers Management Might Be Its Most Valuable Asset
Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...
Fierce Healthcare6d
Hims & Hers expands into Canada as generic semaglutide drug market opens up
The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.
Hims & Hers Health, Inc. (HIMS) Announces Expansion To Canada
Hims & Hers Health, Inc. (NYSE:HIMS) is among the 13 Best Booming Stocks to Buy Now. On July 9, the digital health and ...
Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership
Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...